According to SoSoValue data, the cryptocurrency market sector generally maintains an upward trend. The AI sector performed well, rising 10.58% in 24 hours, with Siren (SIREN), which had a significant drop yesterday, rebounding sharply by 48.37%. Bittensor (TAO) and Venice Token (VVV) increased by 14.61% and 18.15%, respectively. Meanwhile, btc-42">Bitcoin (BTC) rose 0.48%, staying above $70,000, and Ethereum (ETH) increased by 1.39%, fluctuating narrowly around the $2100 mark.
In other sectors, the Meme sector rose 3.58% in 24 hours, with Fartcoin (FARTCOIN) up 7.89%; the DeFi sector increased by 3.02%, with Hyperliquid (HYPE) up 8.24%; the Layer2 sector rose 1.75%, with Mantle (MNT) up 1.85%; the Layer1 sector increased by 1.23%, with Zcash (ZEC) up 7.07%; the CeFi sector rose 0.92%, with FTX (FTT) up 5.30%; and the PayFi sector increased by 0.89%, with Stellar (XLM) up 9.20%.
Additionally, only the RWA sector saw a slight decline of 0.15%. Within the sector, Sky (SKY) fell by 2.18%, but Ondo Finance (ONDO) rose slightly by 1.31%.
The cryptocurrency sector indices reflecting historical market trends show that the ssiAI, ssiDeFi, and ssiMeme indices increased by 8.58%, 4.74%, and 2.21%, respectively.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.






Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.









Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.